000 | 01207 a2200325 4500 | ||
---|---|---|---|
005 | 20250514035911.0 | ||
264 | 0 | _c20030210 | |
008 | 200302s 0 0 eng d | ||
022 | _a0890-9091 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLogothetis, Christopher | |
245 | 0 | 0 |
_aDocetaxel in the management of advanced or metastatic urothelial tract cancer. _h[electronic resource] |
260 |
_bOncology (Williston Park, N.Y.) _cJun 2002 |
||
300 |
_a107-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPaclitaxel _xadverse effects |
650 | 0 | 4 | _aTaxoids |
650 | 0 | 4 |
_aUrologic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aGemcitabine |
700 | 1 | _aMillikan, Randall | |
773 | 0 |
_tOncology (Williston Park, N.Y.) _gvol. 16 _gno. 6 Suppl 6 _gp. 107-11 |
|
999 |
_c12000257 _d12000257 |